These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24246874)

  • 1. [Pathological features of prostate basal cell lesions].
    Wang GW; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):483-6. PubMed ID: 24246874
    [No Abstract]   [Full Text] [Related]  

  • 2. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
    Vorobĭova LR
    Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basal cell carcinoma of prostate: clinicopathologic analysis of two cases].
    Zhu Y; Fan QH; Zhou ZS; Zhang ZH; Wang C; Zhang WM; Song GX
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):477-8. PubMed ID: 19781196
    [No Abstract]   [Full Text] [Related]  

  • 4. [Benign mimickers of prostatic adenocarcinoma: diagnostic features and differential diagnosis].
    Cheng L; Huang W; Li Y; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):52-8. PubMed ID: 24713255
    [No Abstract]   [Full Text] [Related]  

  • 5. Basal cell adenoma of prostate.
    Atik E; Unsal I
    Urol Res; 2004 Dec; 32(6):421-2. PubMed ID: 15551094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.
    Stephan C; Jung K; Diamandis EP; Rittenhouse HG; Lein M; Loening SA
    Urology; 2002 Jan; 59(1):2-8. PubMed ID: 11796270
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
    Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
    Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Florid basal cell hyperplasia of the prostate: a histological, ultrastructural, and immunohistochemical analysis.
    Yang XJ; Tretiakova MS; Sengupta E; Gong C; Jiang Z
    Hum Pathol; 2003 May; 34(5):462-70. PubMed ID: 12792920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate.
    Dema A; Tudose N
    Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal neuroendocrine differentiation in prostatic gland carcinoma with basaloid pattern.
    Gligorijević JV; Velicković LV; Jancić SA; Radovanović Z; Krstić MS; Katić VV
    Vojnosanit Pregl; 2011 Jun; 68(6):515-8. PubMed ID: 21818920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological aspects of prostate cancer and benign nodular hyperplasia.
    Wernert N; Bieroff E; Hügel A
    Anticancer Res; 1997; 17(4B):2907-10. PubMed ID: 9329560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression.
    Montironi R; Mazzucchelli R; Stramazzotti D; Scarpelli M; López Beltran A; Bostwick DG
    J Clin Pathol; 2005 Mar; 58(3):290-6. PubMed ID: 15735163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoforms of prostate-specific antigen in serum: a result of the glycosylation process in dysplastic prostatic cells?
    Jung K; Lein M; Henke W; Schnorr D; Loening SA
    Prostate; 1996 Jul; 29(1):65-6. PubMed ID: 8685058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study.
    Grignon DJ; Ro JY; Ordoñez NG; Ayala AG; Cleary KR
    Hum Pathol; 1988 Dec; 19(12):1425-33. PubMed ID: 2461340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of ubiquitin in human prostate gland.
    Bataineh ZM; Habbal O
    Neuro Endocrinol Lett; 2006 Aug; 27(4):517-22. PubMed ID: 16892003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biosynthetic and proliferative characteristics of the prostatic epithelium in nodular hyperplasia, in cancer and in the peritumoral area].
    Fedosenko KV
    Vopr Onkol; 2002; 48(1):47-9. PubMed ID: 12101565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohyperplastic prostatic adenocarcinoma.
    Humphrey PA; Kaleem Z; Swanson PE; Vollmer RT
    Am J Surg Pathol; 1998 Oct; 22(10):1239-46. PubMed ID: 9777986
    [No Abstract]   [Full Text] [Related]  

  • 20. Consultation case: prostate (prostatectomy)--adenoid basal-cell tumor --multifocal basal-cell hyperplasia.
    Reed RJ
    Am J Surg Pathol; 1984 Sep; 8(9):699-704. PubMed ID: 6206734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.